Company Active LTD

Company profile

Nanna Therapeutics Limited

Nanna Therapeutics

Nanna Therapeutics Limited is a UK company with status active founded in 2012 based in East of England.

CRN
08328823
Founded
2012
Age
13

Overview

Legal name
ASTELLAS ENGINEERED SMALL MOLECULES U.K. LIMITED
Region
East of England
Registered address
MERRIFIELD CENTRE
ROSEMARY LANE
CAMBRIDGE
CB1 3LQ
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Nanna Therapeutics Limited
CRN 08328823
2
Direct and ultimate controller Active LTD

Company events

Reference milestones and recent Companies House filing stream events.

18 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

19 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

05 Nov
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

20 Nov
2024

Second Filing Of Confirmation Statement With Made Up Date

Confirmation-statement

RP04CS01 | Transaction MzQ0NDA5MjA1OGFkaXF6a2N4

Published 20 Nov 2024 02:43

15 Nov
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0MzUzODgwNmFkaXF6a2N4 | Paper/PDF filed

Published 23 Nov 2024 11:06

01 Oct
2024

Second Filing Capital Allotment Shares

Capital

RP04SH01 | Transaction MzQzNzcxMTIyN2FkaXF6a2N4

Published 01 Oct 2024 09:33

30 Sep
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzNzcxNDk4MmFkaXF6a2N4

Published 30 Sep 2024 10:53

29 Sep
2024

Second Filing Capital Allotment Shares

Capital

RP04SH01 | Transaction MzQzNzIxOTU3M2FkaXF6a2N4

Published 29 Sep 2024 11:16

29 Sep
2024

Second Filing Capital Allotment Shares

Capital

RP04SH01 | Transaction MzQzNzIwODczMmFkaXF6a2N4

Published 29 Sep 2024 11:04

29 Sep
2024

Second Filing Capital Allotment Shares

Capital

RP04SH01 | Transaction MzQzNzIwNjI1MmFkaXF6a2N4

Published 29 Sep 2024 07:41

28 Sep
2024

Second Filing Capital Allotment Shares

Capital

RP04SH01 | Transaction MzQzNzIxODA1MmFkaXF6a2N4

Published 28 Sep 2024 07:17

28 Nov
2023

Capital Allotment Shares

Capital

SH01 | Transaction MzQwMTczNzA1MGFkaXF6a2N4 | Paper/PDF filed

Published 03 Oct 2024 06:35

10 Aug
2023

Capital Allotment Shares

Capital

SH01 | Transaction MzM4OTE4ODA3MWFkaXF6a2N4 | Paper/PDF filed

Published 30 Sep 2024 05:38

07 Aug
2023

Capital Allotment Shares

Capital

SH01 | Transaction MzM4ODgwMzU2NGFkaXF6a2N4 | Paper/PDF filed

Published 29 Sep 2024 05:55

31 Jul
2023

Capital Allotment Shares

Capital

SH01 | Transaction MzM4ODA5MjE0N2FkaXF6a2N4 | Paper/PDF filed

Published 30 Sep 2024 05:39

19 Apr
2023

Capital Allotment Shares

Capital

SH01 | Transaction MzM3Njg2OTAyMGFkaXF6a2N4 | Paper/PDF filed

Published 30 Sep 2024 05:40

12 Dec
2012

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2017
Funded years
2017, 2019
Age at first award
4 years

Projects

2019 Feasibility Studies Lead participant

Transforming Drug Discovery by Nanoscale Chemistry and Screening Enabled by Machine Learning

1 Feb 2019 to 31 Jan 2020

Awarded
£580,924
Total cost £829,892

Nanna Therapeutics has invented a ground-breaking set of technologies which has the potential to change the way in which medicines are discovered, in terms of efficacy, safety, speed and cost. This could provide the UK economy a major boost by providing vastly expanded discovery capabilities and increased productivity to the wider pharmaceutical industry....

2017 Collaborative R&D Lead participant

Discovering Novel Antibiotics Agianst Highly Resistent Gram Negative Pathogens

1 Jan 2017 to 31 Mar 2019

Awarded
£917,760
Total cost £1,311,085

Nearly all of us have taken antibiotics: they really are a 'wonder drug' saving millions of lives every year, by specifically killing bacteria. They are rapidly becoming less effective as bacteria develop ways to resist them. An example of this is the spread of MRSA in hospitals. A recent review (The O'Neill Report) conducted by the UK government with the...

Product types

Collaborative R&D Feasibility Studies